Navigation Links
Dimension Xpand Plus Integrated Chemistry System

ProductsDimension Xpand Plus Integrated Chemistry System
Company Dade Behring, Inc.
Item Dimension Xpand Plus Integrated Chemistry System
Features 
  • Ease of Use - Extensive automated features to reduce hands-on time and increase walk away capability
  • Easy Maintenance - Less than 10 minute hands-on daily and weekly maintenance
  • Menu - 70+ Methods available on a single analyzer to achieve workstation consolidation
  • Reagent Management - No reagent preparation and long calibration stability for routine chemistries
  • Result Turnaround Time - STAT capability, 5 1/2 minute 7-test basic chemistry panel
  • Sample Management - Capable of handling various size bar-coded tubes, SSC, and sample cups
Description The Dimension Xpand integrated chemistry system brings versatility in a very compact footprint to the smaller laboratory. A model of innovation and integration, the Dimension Xpand integrated chemistry system features state-of-the-art Dimension technology, specifically tailored for the low-volume testing environment, in a flexible, affordable, easy-to-use system to give you more of what you want.
Info Dade Behring, Inc.Call Dade Behring, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-262-8155

Customer Service: 1-847-267-5300
Web site: http://www.dadebehring.com

Related medicine products :

1. Freshlook Dimensions
2. Dimension AR IMT 110V/60HZ
3. Dimension AR IMT 220V/50HZ
4. Dimension RxL Max™ Integrated Chemistry System 50/60HZ
5. Dimension RxL Max™ Integrated Chemistry System
6. Dimension Arx
7. Dimension AR IMT 220V/50HZ
8. Dimension RxL Max w/HM 50/60HZ
9. Dimension RxL Max w/o HM 50/60 HZ
10. Dimension Xpand
11. DFS Dimension Distal Radius Fixation System
Torso Brief Bodysuit V-BA85
Body Suit w/Bra knee length
Body Suit w/Bra torso
CDIs 2-Panel Abdominal Binders are designed with a foam backing which provides comfort, support and compression without slippage.
Medicine Products:
(Date:12/3/2008)... Specialties Inc., a leading specialty chemicals c... effective January 1, 2009 for 2-vinylpyridine mon...e increase is necessary to continue the company,s ...etter supply chain logistics to its global custome... , , Vertellus is a specialty chemicals co...
(Date:12/3/2008)...he classic saying goes, "You can,never be too ric...would rather,look younger than be rich or thin. ...reveals that on average, women would be willing to...ke them look 10 years younger than they would,on .... , The survey, which was conducted among 1...
(Date:12/3/2008)...ay they work, change, and even "freeze" sometimes....cience (AAAS) recommends that parents, teachers an... and high school students this holiday season in a..., "Parents need every tool they can find to convin...during the holiday season," says Shirley Malcom, h...
(Date:12/3/2008)... device manufacturers should,start initiating str... the,amended European Union Medical Device Direct...sed Nerac white paper urges. , "At stake is...6 billion,market that accounts for a significant ... profits," write Nerac Medical Device Analysts Deb...
Breaking Medicine News(10 mins):Health News:What Will Women Give Up for Skin Health? 2Health News:When 'just say no' isn't enough: Try science 2Health News:New Requirements of EU Medical Device Directive Need Immediate Action, Nerac Analysts Urge in Newly Published White Paper 2Health News:New Requirements of EU Medical Device Directive Need Immediate Action, Nerac Analysts Urge in Newly Published White Paper 3
...ve developed modified skin cells which on being ad...ff potentially lethal infections in patients with ...wn in a laboratory using cells from a burn patient... expanded and combined with a spongy layer of coll...
...re increasingly going in for homeopathic treatment...ood reasons behind the shift, said doctors at a ho...ief, more and more people are following homeopathy...tages. Since allopathy cannot cure all critical or...
... dieters swear by Skim milk and in their interest ...om their diet//. A study was conducted recently w... one serving of whole milk or cheese each day. The... women had gained less weight as compared to those...
...s in the state of California heaved a sigh of reli...was no relation between the meningitis// and the e...e. Officials have clearly indicated that the bact..., are completely different. Encephalitis is caused...
Other Medicine News:Health News:Genetically Altered Cells Prevent Lethal Infections in Substituted Skin 2Health News:Homeopathy can Cure Many Chronic Diseases 2
(Date:12/1/2008)...hosphatasia Treated With ENB-0040 at Children,s Ho..., MONTREAL, Dec. 1 Enobia Pharma...developing novel therapeutics for serious bone dis...ent in its clinical program for hypophosphatasia w...nt Therapy (ERT) with ENB-0040 for the treatment o...
(Date:12/1/2008)...rk, December 1 Following...ntent to procure an MVA-based,third generation s...ces,Canada, on behalf of the Canadian Department ...varian Nordic for the delivery of IMVAMUNE(R). , ...UNE(R) as part of the,country,s bio-preparedness ...
(Date:11/30/2008)... Dec. 1 Older adults wh... flow and a greater number of small blood vessels ...y at the annual meeting of the Radiological Societ...conducted at the University of North Carolina ( ... scans of older adults who exercise to brain scans...
(Date:11/27/2008)...majority of acute lymphoblastic leukemia relapse c... of diagnosis , , MEMPHIS, Tenn., Nov. 27 /...hildren,s Research Hospital have identified distin...ren with acute lymphoblastic leukemia (ALL) that c...gning treatments for ALL relapse in children and, ...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kiadis Pharma Announces Successful Completion of Rhitol 28TM 29 Phase II Clinical Study 10598 1Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 2889 1Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 2889 2Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 2889 3Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 1Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 2Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 3Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 4Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 5Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 6Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 7Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 8Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 9Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 10Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 11Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 12Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 13Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 14Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 15Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 16Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 17Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 18Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 19Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 20Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 21Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 22Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 23Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 24Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 25Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 26Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 27Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 28Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 29Bridges to Excellence Launches Medical Home Program 10592 1Bridges to Excellence Launches Medical Home Program 10592 2Bridges to Excellence Launches Medical Home Program 10592 3Bridges to Excellence Launches Medical Home Program 10592 4
...h Co-Primary Endpoints, Wake After Sleep Onset and...cluding Latency to Persistent,Sleep, Were Met at B...une 04, 2007,/PRNewswire-FirstCall/ -- Evotec AG a...first phase II clinical trial of EVT 201,in patien...tial,positive allosteric modulator (pPAM) of the G...
...CAGO--(BUSINESS WIRE)--Jun 4, 2007 - Genentech, In... a joint analysis of two Phase,III clinical trials...ant treatment of HER2-positive breast cancer. Data...can Society of Clinical,Oncology (ASCO) showed tha...e addition of Herceptin to standard adjuvant thera...
Other Medicine Technology:Evotec Reports Positive Proof-of-Concept Top-Line Results with,Insomnia Drug Candidate EVT 201 2Evotec Reports Positive Proof-of-Concept Top-Line Results with,Insomnia Drug Candidate EVT 201 3Evotec Reports Positive Proof-of-Concept Top-Line Results with,Insomnia Drug Candidate EVT 201 4Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 2Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 3Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 4Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 5Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 6